Skip to content

Myovant Sciences Ltd.

Delisted

CIK 1679082fmd_1EC6JVHZ3QKJPQ7VFCDN37XEZKManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2016 to Dec 31, 2022, 27 periods

Latest annual · FY2022

Millions
Total revenues
231
Operating income
(187)
Net income
(206)
Free cash flow
(270)

Latest quarter · Q3 FY2023

Millions
Total revenues
100
Operating income
(52)
Net income
(58)
Free cash flow
(103)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
n/m
Revenue, 5 yearsFY2017 to FY2022
n/m
Net income, 5 yearsFY2017 to FY2022
n/m

Myovant Sciences Ltd. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$231 million$59.3 million+289.4%10-K 2022-05-11 · proof
Operating income-$187.3 million-$260.8 million10-K 2022-05-11 · proof
Net income-$206 million-$255.1 million10-K 2022-05-11 · proof
Cash from operating activities-$268.6 million$370.6 million-172.5%10-K 2022-05-11 · proof
Free cash flow-$269.5 million$368.9 million-173.1%10-K 2022-05-11 · proof
Total assets$520 million$725 million-28.3%10-K 2022-05-11 · proof
Total liabilities$993.5 million$1.1 billion-7.9%10-K 2022-05-11 · proof
Cash and cash equivalents$406.7 million$674.5 million-39.7%10-K 2022-05-11 · proof
What was Myovant Sciences Ltd.'s revenue in fiscal 2022?
Myovant Sciences Ltd. reported revenue of $231 million for fiscal 2022 (the year ended Mar 31, 2022), against $59.3 million the year before (+289.4%). Source: the 10-K filed with the SEC on May 11, 2022. SEC
What was Myovant Sciences Ltd.'s operating income in fiscal 2022?
Myovant Sciences Ltd. reported operating income of -$187.3 million for fiscal 2022 (the year ended Mar 31, 2022), against -$260.8 million the year before. Source: the 10-K filed with the SEC on May 11, 2022. SEC
What was Myovant Sciences Ltd.'s net income in fiscal 2022?
Myovant Sciences Ltd. reported net income of -$206 million for fiscal 2022 (the year ended Mar 31, 2022), against -$255.1 million the year before. Source: the 10-K filed with the SEC on May 11, 2022. SEC
What was Myovant Sciences Ltd.'s cash from operating activities in fiscal 2022?
Myovant Sciences Ltd. reported cash from operating activities of -$268.6 million for fiscal 2022 (the year ended Mar 31, 2022), against $370.6 million the year before (-172.5%). Source: the 10-K filed with the SEC on May 11, 2022. SEC
What was Myovant Sciences Ltd.'s free cash flow in fiscal 2022?
Myovant Sciences Ltd. reported free cash flow of -$269.5 million for fiscal 2022 (the year ended Mar 31, 2022), against $368.9 million the year before (-173.1%). Source: the 10-K filed with the SEC on May 11, 2022. SEC
What are Myovant Sciences Ltd.'s total assets?
As of Mar 31, 2022, Myovant Sciences Ltd. reported total assets of $520 million, against $725 million a year earlier (-28.3%). Source: the 10-K filed with the SEC on May 11, 2022. SEC
What are Myovant Sciences Ltd.'s total liabilities?
As of Mar 31, 2022, Myovant Sciences Ltd. reported total liabilities of $993.5 million, against $1.1 billion a year earlier (-7.9%). Source: the 10-K filed with the SEC on May 11, 2022. SEC
What are Myovant Sciences Ltd.'s cash and cash equivalents?
As of Mar 31, 2022, Myovant Sciences Ltd. reported cash and cash equivalents of $406.7 million, against $674.5 million a year earlier (-39.7%). Source: the 10-K filed with the SEC on May 11, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1679082&period_type=annual&limit=5"

Information only, not investment advice.